Unveiling the therapeutic potential of crispr-cas9 technology in the correction of SCD gene mutation
Sickle-cell disease is a genetic disorder caused by the substitution of normal hemoglobin with abnormal hemoglobin due to a mutation in the HBB gene. Only a few temporary, symptomatically highly effective treatments are available for this disorder; Therefore, there is a dire need to find more effect...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Global Sciences
2025-06-01
|
| Series: | Cellular, Molecular and Biomedical Reports |
| Subjects: | |
| Online Access: | https://www.cmbr-journal.com/article_205878_e302dfc5336685046ad6025436057fbf.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|